166 related articles for article (PubMed ID: 26458938)
21. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.
Timsit JF; Schwebel C; Bouadma L; Geffroy A; Garrouste-Orgeas M; Pease S; Herault MC; Haouache H; Calvino-Gunther S; Gestin B; Armand-Lefevre L; Leflon V; Chaplain C; Benali A; Francais A; Adrie C; Zahar JR; Thuong M; Arrault X; Croize J; Lucet JC;
JAMA; 2009 Mar; 301(12):1231-41. PubMed ID: 19318651
[TBL] [Abstract][Full Text] [Related]
22. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States.
Ye X; Rupnow M; Bastide P; Lafuma A; Ovington L; Jarvis WR
Am J Infect Control; 2011 Oct; 39(8):647-654. PubMed ID: 21641681
[TBL] [Abstract][Full Text] [Related]
23. Devices and dressings to secure peripheral venous catheters to prevent complications.
Marsh N; Webster J; Mihala G; Rickard CM
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011070. PubMed ID: 26068958
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the efficacy of three topical antiseptic solutions for the prevention of catheter colonization: a multicenter randomized controlled study.
Yasuda H; Sanui M; Abe T; Shime N; Komuro T; Hatakeyama J; Matsukubo S; Kawano S; Yamamoto H; Andoh K; Seo R; Inoue K; Noda E; Saito N; Nogami S; Okamoto K; Fuke R; Gushima Y; Kobayashi A; Takebayashi T; Lefor AK;
Crit Care; 2017 Dec; 21(1):320. PubMed ID: 29268759
[TBL] [Abstract][Full Text] [Related]
25. Differences in microorganism growth on various dressings used to cover injection sites: inspection of the risk of catheter-related bloodstream infections caused by Gram-negative bacilli.
Kawamura H; Takahashi N; Takahashi M; Taketomi A
Surg Today; 2014 Dec; 44(12):2339-44. PubMed ID: 24871954
[TBL] [Abstract][Full Text] [Related]
26. Chlorhexidine gluconate-impregnated central-line dressings and necrosis in complicated skin disorder patients.
Wall JB; Divito SJ; Talbot SG
J Crit Care; 2014 Dec; 29(6):1130.e1-4. PubMed ID: 25035049
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of a novel adhesive containing chlorhexidine gluconate (CHG) against the resident microflora in human volunteers.
Carty N; Wibaux A; Ward C; Paulson DS; Johnson P
J Antimicrob Chemother; 2014 Aug; 69(8):2224-9. PubMed ID: 24722839
[TBL] [Abstract][Full Text] [Related]
28. Chlorhexidine gluconate dressings reduce bacterial colonization rates in epidural and peripheral regional catheters.
Kerwat K; Eberhart L; Kerwat M; Hörth D; Wulf H; Steinfeldt T; Wiesmann T
Biomed Res Int; 2015; 2015():149785. PubMed ID: 25879016
[TBL] [Abstract][Full Text] [Related]
29. The effectiveness of dressings and securement devices to prevent central venous catheter-associated complications: A systematic review and meta-analysis.
Xu H; Hyun A; Mihala G; Rickard CM; Cooke ML; Lin F; Mitchell M; Ullman AJ
Int J Nurs Stud; 2024 Jan; 149():104620. PubMed ID: 37879273
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of chlorhexidine dressings to prevent catheter-related bloodstream infections. Does one size fit all? A systematic literature review and meta-analysis.
Puig-Asensio M; Marra AR; Childs CA; Kukla ME; Perencevich EN; Schweizer ML
Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1388-1395. PubMed ID: 32935659
[TBL] [Abstract][Full Text] [Related]
31. Chlorhexidine gluconate–impregnated central access catheter dressings as a cause of erosive contact dermatitis: a report of 7 cases.
Weitz NA; Lauren CT; Weiser JA; LeBoeuf NR; Grossman ME; Biagas K; Garzon MC; Morel KD
JAMA Dermatol; 2013 Feb; 149(2):195-9. PubMed ID: 23560299
[TBL] [Abstract][Full Text] [Related]
32. Early prophylaxis of central venous catheter-related thrombosis using 1% chlorhexidine gluconate and chlorhexidine-gel-impregnated dressings: a retrospective cohort study.
Yamashita T; Takamori A; Nakagawachi A; Tanigawa Y; Hamada Y; Aoki Y; Sakaguchi Y
Sci Rep; 2020 Sep; 10(1):15952. PubMed ID: 32994455
[TBL] [Abstract][Full Text] [Related]
33. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
[TBL] [Abstract][Full Text] [Related]
34. 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial.
Clarke P; Soe A; Nichols A; Harizaj H; Webber MA; Linsell L; Bell JL; Tremlett C; Muthukumar P; Pattnayak S; Partlett C; King A; Juszczak E; Heath PT
Arch Dis Child Fetal Neonatal Ed; 2024 Feb; 109(2):202-210. PubMed ID: 37907266
[TBL] [Abstract][Full Text] [Related]
35. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial).
Webster J; Larsen E; Marsh N; Choudhury A; Harris P; Rickard CM
J Hosp Infect; 2017 Jul; 96(3):223-228. PubMed ID: 28526171
[TBL] [Abstract][Full Text] [Related]
36. Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years.
Karlnoski R; Abboud EC; Thompson P; Oxner AZ; Sinnott JT; Marcet JE
J Intensive Care Med; 2019 Jul; 34(7):544-549. PubMed ID: 29216782
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
Clarke P; Craig JV; Wain J; Tremlett C; Linsell L; Bowler U; Juszczak E; Heath PT
BMJ Open; 2019 Feb; 9(2):e028022. PubMed ID: 30782955
[TBL] [Abstract][Full Text] [Related]
38. Cost effectiveness of dressing in the prevention of catheter-related infection in critically ill patients.
Pedrolo E; Danski MTR; Wiens A; Boostel R
J Infect Dev Ctries; 2018 Oct; 12(10):871-877. PubMed ID: 32004156
[TBL] [Abstract][Full Text] [Related]
39. Chlorhexidine and gauze and tape dressings for central venous catheters: a randomized clinical trial.
Pedrolo E; Danski MT; Vayego SA
Rev Lat Am Enfermagem; 2014 Oct; 22(5):764-71. PubMed ID: 25493671
[TBL] [Abstract][Full Text] [Related]
40. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, combined or not with use of a bundle of new devices, for prevention of short-term peripheral venous catheter-related infectious complications and catheter failure: an open-label, single-centre, randomised, four-parallel group, two-by-two factorial trial: CLEAN 3 protocol study.
Guenezan J; Drugeon B; O'Neill R; Caillaud D; Sénamaud C; Pouzet C; Seguin S; Frasca D; Mimoz O
BMJ Open; 2019 Apr; 9(4):e028549. PubMed ID: 30944142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
